$VERB
Verb Technology Company, Inc. Stock $verb

$verb Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028599 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$29.00K	$1.601M	$2.399M
YoY Change	-98.67%	-33.26%	0.29%
Cost Of Revenue	$5.000K	$1.000K	$835.0K
YoY Change	-99.32%	-99.88%	-25.38%
Gross Profit	$24.00K	$2.000K	$1.564M
YoY Change	-98.35%	-99.87%	22.86%
Gross Profit Margin	82.76%	0.12%	65.19%
Selling, General & Admin	$2.850M	$2.685M	$6.562M
YoY Change	-59.08%	-59.08%	0.31%
% of Gross Profit	11875.0%	134250.0%	419.57%
Research & Development			$1.382M
YoY Change			-56.99%
% of Gross Profit			88.36%
Depreciation & Amortization	$560.0K	$511.0K	$0.00
YoY Change	-33.33%
% of Gross Profit	2333.33%	25550.0%	0.0%
Operating Expenses	$3.414M	$3.268M	$8.339M
YoY Change	-62.59%	-60.81%	-17.88%
Operating Profit	-$3.390M	-$3.266M	-$6.775M
YoY Change	-55.84%	-51.79%	-23.72%
Interest Expense	$219.0K	$299.0K	$642.0K
YoY Change	-60.18%	-53.43%	7.72%
% of Operating Profit
Other Income/Expense, Net	-$151.0K	-$510.0K	$401.0K
YoY Change	-57.1%	-227.18%	-113.69%
Pretax Income	-$3.540M	-$3.776M	-$6.374M
YoY Change	-55.9%	-40.76%	-46.04%
Income Tax
% Of Pretax Income
Net Earnings	-$3.709M	-$9.856M	-$6.374M
YoY Change	-53.8%	54.63%	-46.04%
Net Earnings / Revenue	-12789.66%	-615.62%	-265.69%
Basic Earnings Per Share	-$0.68	-$2.45	-$0.07
Diluted Earnings Per Share	-$0.68	-$2.45	-$65.74K
COMMON SHARES
Basic Shares Outstanding	4.501M shares	154.8M shares	96.95M shares
Diluted Shares Outstanding	5.421M shares	4.023M shares	2.424M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$920.0K	$3.526M	$5.547M
YoY Change	-0.11%	-36.43%	-13.99%
Cash & Equivalents	$918.0K	$3.526M	$5.547M
Short-Term Investments
Other Short-Term Assets	$400.0K	$238.0K	$894.0K
YoY Change	-45.8%	-73.38%	-29.33%
Inventory
Prepaid Expenses			$894.0K
Receivables			$1.816M
Other Receivables			$0.00
Total Short-Term Assets	$1.318M	$3.764M	$8.257M
YoY Change	-57.44%	-54.41%	-4.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$39.00K	$449.0K	$627.0K
YoY Change	-93.3%	-28.39%	-80.52%
Goodwill			$19.76M
YoY Change
Intangibles	$97.00K	$83.00K	$3.318M
YoY Change	-96.73%	-97.5%
Long-Term Investments
YoY Change
Other Assets	$259.0K	$294.0K	$306.0K
YoY Change	-15.36%	-3.92%	356.72%
Total Long-Term Assets	$6.750M	$8.696M	$32.15M
YoY Change	-78.7%	-72.95%	15.76%
TOTAL ASSETS
Total Short-Term Assets	$1.318M	$3.764M	$8.257M
Total Long-Term Assets	$6.750M	$8.696M	$32.15M
Total Assets	$8.068M	$12.46M	$40.41M
YoY Change	-76.8%	-69.16%	10.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.706M	$2.786M	$3.413M
YoY Change	-29.4%	-18.37%	-28.15%
Accrued Expenses	$2.080M	$1.433M	$3.466M
YoY Change	-45.99%	-58.66%	51.09%
Deferred Revenue			$1.614M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.610M	$6.370M	$4.120M
YoY Change	-37.43%	54.61%	2610.53%
Total Short-Term Liabilities	$8.457M	$12.75M	$14.16M
YoY Change	-48.42%	-9.96%	-27.13%
LONG-TERM LIABILITIES
Long-Term Debt	$140.0K	$150.0K	$875.0K
YoY Change	-6.67%	-82.86%	0.0%
Other Long-Term Liabilities	$180.0K	$1.379M	$1.841M
YoY Change	-89.44%	-25.1%	-29.95%
Total Long-Term Liabilities	$320.0K	$1.529M	$2.716M
YoY Change	-82.75%	-43.7%	-22.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.457M	$12.75M	$14.16M
Total Long-Term Liabilities	$320.0K	$1.529M	$2.716M
Total Liabilities	$8.783M	$14.28M	$16.88M
YoY Change	-51.88%	-15.39%	-26.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$172.7M	-$169.0M	-$129.4M
YoY Change	25.68%	30.61%
Common Stock	$1.000K	$1.000K	$10.00K
YoY Change	-90.0%	-90.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$715.0K	-$1.818M	$23.53M
YoY Change
Total Liabilities & Shareholders Equity	$8.068M	$12.46M	$40.41M
YoY Change	-76.8%	-69.16%	10.94%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$3.709M	-$9.856M	-$6.374M
YoY Change	-53.8%	54.63%	-46.04%
Depreciation, Depletion And Amortization	$560.0K	$511.0K	$0.00
YoY Change	-33.33%
Cash From Operating Activities	-$1.930M	-$3.622M	-$5.103M
YoY Change	-61.19%	-29.02%	-23.84%
INVESTING ACTIVITIES
Capital Expenditures	$40.00K	$113.0K	-$1.848M
YoY Change	-120.94%	-106.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$4.750M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$30.00K	$4.637M	-$1.848M
YoY Change	-84.29%	-350.92%	-184900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-640.0K	-1.279M	8.780M
YoY Change	-218.96%	-114.57%	4449.22%
NET CHANGE
Cash From Operating Activities	-1.930M	-3.622M	-5.103M
Cash From Investing Activities	-30.00K	4.637M	-1.848M
Cash From Financing Activities	-640.0K	-1.279M	8.780M
Net Change In Cash	-2.600M	-264.0K	1.829M
YoY Change	-43.8%	-114.43%	-128.11%
FREE CASH FLOW
Cash From Operating Activities	-$1.930M	-$3.622M	-$5.103M
Capital Expenditures	$40.00K	$113.0K	-$1.848M
Free Cash Flow	-$1.970M	-$3.735M	-$3.255M
YoY Change	-58.8%	14.75%	-51.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Entity Central Index Key EntityCentralIndexKey	0001566610
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022Q2	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
	VERB	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
	VERB	Finance Costs FinanceCosts		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
	VERB	Fair Value Of Common Shares Issued As Payment On Notes Payable FairValueOfCommonSharesIssuedAsPaymentOnNotesPayable		usd
	VERB	Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes		usd
	VERB	Accrued Capitalized Software Development Costs AccruedCapitalizedSoftwareDevelopmentCosts		usd
	VERB	Discount Recognized From Notes Payable DiscountRecognizedFromNotesPayable		usd
	VERB	Discount Recognized From Advances On Future Receipts DiscountRecognizedFromAdvancesOnFutureReceipts		usd
	VERB	Derecognition Of Operating Lease Right Of Use Assets DerecognitionOfOperatingLeaseRightOfUseAssets		usd
	VERB	Derecognition Of Operating Lease Liabilities DerecognitionOfOperatingLeaseLiabilities		usd
	VERB	Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38834
	dei	Entity Registrant Name EntityRegistrantName	Verb Technology Company, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1118043
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3401 North Thanksgiving Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 240
	dei	Entity Address City Or Town EntityAddressCityOrTown	Lehi
	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84043
	dei	City Area Code CityAreaCode	(855)
	dei	Local Phone Number LocalPhoneNumber	250-2300
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4501340	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3526000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2429000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1323000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	238000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	306000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	3764000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4058000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	10467000	usd
CY2023Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	5122000	usd
CY2022Q4	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	6176000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	1528000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Noncurrent AccountsReceivableNetNoncurrent	1528000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	449000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	533000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1220000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1354000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	83000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	294000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	293000	usd
CY2023Q2	us-gaap	Assets Assets	12460000	usd
CY2022Q4	us-gaap	Assets Assets	24492000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2786000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3975000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2483000	usd
CY2023Q2	VERB	Liabilities Of Discontinued Operations LiabilitiesOfDiscontinuedOperations	898000	usd
CY2022Q4	VERB	Liabilities Of Discontinued Operations LiabilitiesOfDiscontinuedOperations	1641000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1433000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1287000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	764000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	764000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1334000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	482000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	355000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	16000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	222000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	12749000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16530000	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1215000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1379000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1581000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	14278000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19326000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4317561	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4317561	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2918017	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2918017	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	167179000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	158629000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-168998000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-153464000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1818000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5166000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12460000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24492000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	1000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	2000	usd
	us-gaap	Gross Profit GrossProfit	3000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	583000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1166000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	86000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2685000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4760000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6230000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9893000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	3268000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	4804000	usd
	us-gaap	Operating Expenses OperatingExpenses	7396000	usd
	us-gaap	Operating Expenses OperatingExpenses	9979000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3266000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4804000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7393000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9979000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	831000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	780000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16000	usd
CY2023Q2	VERB	Financing Costs FinancingCosts	-1239000	usd
	VERB	Financing Costs FinancingCosts	-1239000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	299000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	368000	usd
	us-gaap	Interest Expense InterestExpense	770000	usd
	us-gaap	Interest Expense InterestExpense	661000	usd
CY2023Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	198000	usd
CY2022Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1024000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	206000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-510000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	675000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1023000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1485000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3776000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4129000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8416000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8494000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6080000	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2245000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6954000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4869000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-9856000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-6374000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15370000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13363000	usd
	VERB	Deemed Dividend Due To Warrant Reset DeemedDividendDueToWarrantReset	164000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9856000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6374000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15534000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13363000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.45
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.45
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.16
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.45
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.45
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-6.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-6.16
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4022947	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4022947	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2423831	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2423831	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3801599	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3801599	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2169057	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2169057	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4022947	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4022947	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2423831	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2423831	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3801599	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3801599	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2169057	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2169057	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5166000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	6578000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1362000	usd
	VERB	Stock Issued During Period Value To Settle Accrued Expenses StockIssuedDuringPeriodValueToSettleAccruedExpenses	146000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15370000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1818000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	13322000	usd
	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	20150000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	377000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1126000	usd
	VERB	Stock Issued During Period Value To Settle Accounts Payable And Accrued Expenses StockIssuedDuringPeriodValueToSettleAccountsPayableAndAccruedExpenses	450000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1468000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13363000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	23530000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15370000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-13363000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-6954000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4869000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1402000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2618000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	163000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	171000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	127000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	264000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	206000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1166000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	86000	usd
	VERB	Finance Costs FinanceCosts	1239000	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-14000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-66000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	384000	usd
	VERB	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	-134000	usd
	VERB	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	-127000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-285000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	360000	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-377000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-75000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-177000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4685000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7954000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1855000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-3048000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	239000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	4108000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	82000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-244000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4210000	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	4750000	usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6578000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20150000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	6000000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	375000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1896000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1350000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	377000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	445000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4853000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	24186000	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-1722000	usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-4363000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1097000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4610000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2429000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	937000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3526000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5547000	usd
	us-gaap	Sale Of Stock Description Of Transaction SaleOfStockDescriptionOfTransaction	participants in the program can earn between 5% and 20% of their gross sales at no cost and no risk to the Creators selected to participate in the Creator program.
CY2023Q2	us-gaap	Proceeds From Sale Of Other Productive Assets ProceedsFromSaleOfOtherProductiveAssets	6500000	usd
CY2023Q2	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	4750000	usd
CY2023Q2	VERB	Additional Payments Due From Buyer AdditionalPaymentsDueFromBuyer	1750000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8416000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4685000	usd
CY2023Q2	us-gaap	Cash Cash	3526000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	901275	shares
CY2023Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	6578000	usd
CY2023Q1	us-gaap	Partners Capital Account Public Sale Of Units Net Of Offering Costs PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts	622000	usd
CY2023Q1	VERB	Purchase Of Future Receipts Revenues PurchaseOfFutureReceiptsRevenues	2108000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	558000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	915000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	10000	usd
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-11-07
	VERB	Employee Retention Credit Provisions EmployeeRetentionCreditProvisions	1528000	usd
CY2023Q2	VERB	Accrued Payroll Taxes Returns AccruedPayrollTaxesReturns	1528000	usd
CY2022Q4	VERB	Accrued Payroll Taxes Returns AccruedPayrollTaxesReturns	1528000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6500000	usd
CY2023Q2	VERB	Cash Proceeds From Sale Of Productive Assets CashProceedsFromSaleOfProductiveAssets	4750000	usd
CY2023Q2	VERB	Additional Payments Due From Buyer AdditionalPaymentsDueFromBuyer	1750000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	482000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	355000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1379000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zLvERi07uIx8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zGNZeO9UWRjh">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported periods. Significant estimates include assumptions made in analysis of reserves for allowance of doubtful accounts, inventory, assumptions made in purchase price allocations, impairment testing of long-term assets, realization of deferred tax assets, determining fair value of derivative liabilities, and valuation of equity instruments issued for services. Amounts could materially change in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	VERB	Plat Form Fee Description PlatFormFeeDescription	All sales run through our ecommerce facility on MARKET.live from which we deduct a platform fee that ranges from 10% to 20% of gross sales, with an average of approximately 15%,
CY2022	us-gaap	Indefinite Lived Intangible Assets Period Increase Decrease IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease	0	usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	10183000	usd
CY2022	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	9581000	usd
CY2023Q2	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6500000	usd
CY2023Q2	VERB	Cash Proceeds From Sale Of Productive Assets CashProceedsFromSaleOfProductiveAssets	4750000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5441000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1581000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1861000	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_847_eus-gaap--DerivativesReportingOfDerivativeActivity_zqHQPY6T0Mal" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_z91cDBbGdwsb">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the consolidated balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses Level 2 inputs for its valuation methodology for the derivative liabilities as their fair values were determined by using a Binomial pricing model. The Company’s derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjusted to fair value of derivatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zcTz3E2Bpxs8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_868_zrchmmlJKLG7">Concentration of Credit and Other Risks</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and accounts receivable. Cash is deposited with a limited number of financial institutions. The balances held at any one financial institution at times may be in excess of Federal Deposit Insurance Corporation (“FDIC”) insurance limits of up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_pn3n3_c20230630_zI4hIw1R0VO6" title="FDIC Insured Amount">250</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s concentration of credit risk includes its concentrations from key customers and vendors. The details of these significant customers and vendors are presented in the following table for the six months ended June 30, 2023 and 2022:</span></p> <p id="xdx_89D_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_z0YGhDLbqlc3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zole2GYfLPw2" style="display: none">SCHEDULE OF CONCENTRATION RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended June 30,</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left; padding-bottom: 1.5pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2023</b></span></td> <td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2022</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Company’s largest customers are presented below as a percentage of the aggregate</b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues and Accounts receivable</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No customers individually over <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesAndAccountsReceivablesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zgyxzCIVHTG2" title="Revenues and Accounts receivable">10</span>% and in the aggregate</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No customers individually over <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--RevenuesAndAccountsReceivablesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomersMember_zZRFJAA5aEmj" title="Revenues and Accounts receivable">10</span>% and in the aggregate</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Company’s largest vendors are presented below as a percentage of the aggregate</b></span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchases</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One vendor that accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FirstVendorMember_zCVHSMU7yri4" title="Purchases">32</span>% of its purchases individually and in the aggregate</span></td> <td> </td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One vendor that accounted for <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--FirstVendorMember_zRr9xknAvj3d" title="Purchases">44</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220630__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--SecondVendorMember_zg4d1SPgYUEe" title="Purchases">41</span>%, respectively, of its purchases individually and in the aggregate</span></td></tr> </table> <p id="xdx_8AF_z3CfLXFgIg4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1936000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	127000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	264000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	480000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	226000	usd
	us-gaap	Interest Paid Net InterestPaidNet	234000	usd
	us-gaap	Interest Paid Net InterestPaidNet	95000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-1000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accrued Expenses FairValueOfCommonSharesIssuedToSettleAccruedExpenses	146000	usd
	VERB	Fair Value Of Common Shares Issued To Settle Accrued Expenses FairValueOfCommonSharesIssuedToSettleAccruedExpenses	450000	usd
	VERB	Fair Value Of Common Shares Issued As Payment On Notes Payable FairValueOfCommonSharesIssuedAsPaymentOnNotesPayable	300000	usd
	VERB	Fair Value Of Common Stock Received In Exchange For Employees Payroll Taxes FairValueOfCommonStockReceivedInExchangeForEmployeesPayrollTaxes	6000	usd
	VERB	Accrued Capitalized Software Development Costs AccruedCapitalizedSoftwareDevelopmentCosts	105000	usd
	VERB	Discount Recognized From Notes Payable DiscountRecognizedFromNotesPayable	300000	usd
	VERB	Discount Recognized From Advances On Future Receipts DiscountRecognizedFromAdvancesOnFutureReceipts	558000	usd
	VERB	Derecognition Of Operating Lease Right Of Use Assets DerecognitionOfOperatingLeaseRightOfUseAssets	543000	usd
	VERB	Derecognition Of Operating Lease Liabilities DerecognitionOfOperatingLeaseLiabilities	521000	usd
	VERB	Recognition Of Operating Lease Rightofuse Asset And Related Lease Liability RecognitionOfOperatingLeaseRightofuseAssetAndRelatedLeaseLiability	212000	usd
CY2023Q2	VERB	Accrued Other Capitalized Software Development Costs AccruedOtherCapitalizedSoftwareDevelopmentCosts	605000	usd
CY2022Q4	VERB	Accrued Other Capitalized Software Development Costs AccruedOtherCapitalizedSoftwareDevelopmentCosts	604000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6176000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	4348000	usd
	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	23000	usd
CY2022	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	2760000	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1077000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	932000	usd
CY2023Q2	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	5122000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6176000	usd
CY2023Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	57000	usd
CY2022Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	151000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1188000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2377000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1445000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	112000	usd
CY2023Q2	VERB	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	5122000	usd
CY2021Q3	VERB	Break Up Fee Payable BreakUpFeePayable	1000000	usd
CY2021Q3	VERB	Business Combination Consideration Transferred Assumption Description BusinessCombinationConsiderationTransferredAssumptionDescription	the purchase price for the Primary Contractor would have been $12,000, which could be paid in cash and/or stock, although the final terms of the acquisition if pursued will be set forth in the final executed SPA.
CY2023Q2	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6500000	usd
CY2023Q2	VERB	Cash Proceeds From Sale Of Productive Assets CashProceedsFromSaleOfProductiveAssets	4750000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5441000	usd
CY2022Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	1024000	usd
CY2022Q4	VERB	Prepaid Expense And Other Assets Current Held For Sale PrepaidExpenseAndOtherAssetsCurrentHeldForSale	299000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9581000	usd
CY2022Q4	VERB	Longlived Assets And Other Assets Held For Sale LonglivedAssetsAndOtherAssetsHeldForSale	886000	usd
CY2022Q4	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	11790000	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	663000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	1340000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	480000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	2483000	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	165000	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	119000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	299000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	368000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	163000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	171000	usd
CY2023Q2	us-gaap	Revenues Revenues	1601000	usd
CY2022Q2	us-gaap	Revenues Revenues	2399000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-6080000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-2245000	usd
	us-gaap	Revenues Revenues	3814000	usd
	us-gaap	Revenues Revenues	5090000	usd
	us-gaap	Profit Loss ProfitLoss	-6954000	usd
	us-gaap	Profit Loss ProfitLoss	-4869000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	113000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	221000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M1D
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M1D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040	pure
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1220000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1354000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	346000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	472000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	484000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	496000	usd
CY2023Q2	VERB	Lessee Operating Lease Liability Payments Due Four And After Year Four LesseeOperatingLeaseLiabilityPaymentsDueFourAndAfterYearFour	209000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2007000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	146000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1861000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	5830000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	915000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1989000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	187000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	311000	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	32000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	37000	usd
CY2023Q2	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	696000	usd
CY2022Q4	VERB	Advances On Future Receipts Net AdvancesOnFutureReceiptsNet	1641000	usd
CY2023Q2	VERB	Notes Payable Related Parties Debt Discount NotesPayableRelatedPartiesDebtDiscount	-246000	usd
CY2022Q4	VERB	Notes Payable Related Parties Debt Discount NotesPayableRelatedPartiesDebtDiscount	-408000	usd
CY2023Q2	VERB	Notes Payable Related Parties Debt Issuance Costs NotesPayableRelatedPartiesDebtIssuanceCosts	-183000	usd
CY2022Q4	VERB	Notes Payable Related Parties Debt Issuance Costs NotesPayableRelatedPartiesDebtIssuanceCosts	-309000	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	6520000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	7018000	usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	150000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1215000	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	6370000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	5803000	usd
CY2023Q2	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	On May 16, 2023, the Company received a redemption notice under the terms of the November Note Purchase Agreement for $300. The Company missed two payments resulting in a Payment Failure Balance Increase of 10% on the outstanding principal balance per occurrence pursuant to the terms of the agreement totaling $1,205.
CY2023Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	77000	usd
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	98000	usd
	us-gaap	Interest Expense InterestExpense	770000	usd
	us-gaap	Interest Expense InterestExpense	661000	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	16000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	222000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	206000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
CY2023Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	16000	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	222000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	3155000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	206000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	2162000	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	16000	usd
CY2022Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	993000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	901275	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.00
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6578000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	13.60
CY2023Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	8.00
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	reverse stock split of its outstanding shares of common stock at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-forty (1-for-40) split. On April 18, 2023, the Company implemented the 1-for-40 reverse stock split (the “Reverse Stock Split”) of its common stock. The Company’s common stock commenced trading on a post- reverse stock split basis on April 19, 2023. As a result of the Reverse Stock Split, every forty (40) shares of the Company’s pre-Reverse Stock Split common stock were combined and reclassified into one share of common stock
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	89898	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.04
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	147775	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	195489	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	4.87
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	20649	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	40.49
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	21535	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	48.61
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	139054	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	52.11
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M13D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1005685	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	45216	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	48.11
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1099523	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.69
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M10D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	-0	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	77304	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	50.47
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	77304	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	50.47
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0395	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0124	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0301	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.275	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.478	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.495	pure
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	901275	shares
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.00
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	13.60
CY2023Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	8.00
CY2023Q1	VERB	Deemed Dividend Due To Warrant Reset DeemedDividendDueToWarrantReset	164000	usd
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	300000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	915000	usd
CY2023Q1	us-gaap	Loss Contingency Settlement Agreement Court LossContingencySettlementAgreementCourt	On March 1, 2023, BH and the Company entered into an out of court settlement and the Company agreed to pay $25 on execution of the settlement agreement and $6.25 per month over a period of 12 months with a total settlement amount of $100. The total settlement amount was accrued by the Company as of June 30, 2023
	VERB	Board Fees Expense BoardFeesExpense	167000	usd
	VERB	Prepaid Board Fees Expense PrepaidBoardFeesExpense	125000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-028599-index-headers.html	Edgar Link	pending
0001493152-23-028599-index.html	Edgar Link	pending
0001493152-23-028599.txt	Edgar Link	pending
0001493152-23-028599-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
verb-20230630.xsd	Edgar Link	pending
verb-20230630_cal.xml	Edgar Link	unprocessable
verb-20230630_lab.xml	Edgar Link	unprocessable
verb-20230630_def.xml	Edgar Link	unprocessable
verb-20230630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VERB
Verb Technology Company, Inc. Stock $verb

2023 Q3 Form 10-Q Financial Statement

#000149315223028599 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERB Verb Technology Company, Inc. Stock $verb

2023 Q3 Form 10-Q Financial Statement

#000149315223028599 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VERB
Verb Technology Company, Inc. Stock $verb